These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21554564)

  • 1. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD.
    Yeh MS; Mari JJ; Costa MC; Andreoli SB; Bressan RA; Mello MF
    CNS Neurosci Ther; 2011 Oct; 17(5):305-10. PubMed ID: 21554564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder.
    Mello MF; Yeh MS; Barbosa Neto J; Braga LL; Fiks JP; Mendes DD; Moriyama TS; Valente NL; Costa MC; Mattos P; Bressan RA; Andreoli SB; Mari JJ
    BMC Psychiatry; 2009 May; 9():28. PubMed ID: 19480669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study.
    Tucker P; Trautman RP; Wyatt DB; Thompson J; Wu SC; Capece JA; Rosenthal NR
    J Clin Psychiatry; 2007 Feb; 68(2):201-6. PubMed ID: 17335317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.
    Berlant J; van Kammen DP
    J Clin Psychiatry; 2002 Jan; 63(1):15-20. PubMed ID: 11838620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate Monotherapy for Civilian Posttraumatic Stress Disorder: A Controlled Pilot Study.
    Monga V; Petty F; Padala K; Padala PR
    Prim Care Companion CNS Disord; 2023 Oct; 25(5):. PubMed ID: 37857291
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
    Brady K; Pearlstein T; Asnis GM; Baker D; Rothbaum B; Sikes CR; Farfel GM
    JAMA; 2000 Apr; 283(14):1837-44. PubMed ID: 10770145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder.
    Lindley SE; Carlson EB; Hill K
    J Clin Psychopharmacol; 2007 Dec; 27(6):677-81. PubMed ID: 18004136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.
    Tucker P; Zaninelli R; Yehuda R; Ruggiero L; Dillingham K; Pitts CD
    J Clin Psychiatry; 2001 Nov; 62(11):860-8. PubMed ID: 11775045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder.
    Berlant JL
    BMC Psychiatry; 2004 Aug; 4():24. PubMed ID: 15315714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of civilian and combat-related posttraumatic stress disorder with topiramate.
    Andrus MR; Gilbert E
    Ann Pharmacother; 2010 Nov; 44(11):1810-6. PubMed ID: 20923947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo.
    Rothbaum BO; Davidson JR; Stein DJ; Pedersen R; Musgnung J; Tian XW; Ahmed S; Baldwin DS
    J Clin Psychiatry; 2008 Oct; 69(10):1529-39. PubMed ID: 19192435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial.
    Batki SL; Pennington DL; Lasher B; Neylan TC; Metzler T; Waldrop A; Delucchi K; Herbst E
    Alcohol Clin Exp Res; 2014 Aug; 38(8):2169-77. PubMed ID: 25092377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
    Davidson J; Rothbaum BO; Tucker P; Asnis G; Benattia I; Musgnung JJ
    J Clin Psychopharmacol; 2006 Jun; 26(3):259-67. PubMed ID: 16702890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial.
    Mowla A; Kardeh E
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):970-3. PubMed ID: 21291943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.
    Robert S; Hamner MB; Ulmer HG; Lorberbaum JP; Durkalski VL
    J Clin Psychiatry; 2006 Oct; 67(10):1522-6. PubMed ID: 17107242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
    Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate in posttraumatic stress disorder: preliminary clinical observations.
    Berlant JL
    J Clin Psychiatry; 2001; 62 Suppl 17():60-3. PubMed ID: 11495099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.
    Davidson J; Baldwin D; Stein DJ; Kuper E; Benattia I; Ahmed S; Pedersen R; Musgnung J
    Arch Gen Psychiatry; 2006 Oct; 63(10):1158-65. PubMed ID: 17015818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
    Feder A; Costi S; Rutter SB; Collins AB; Govindarajulu U; Jha MK; Horn SR; Kautz M; Corniquel M; Collins KA; Bevilacqua L; Glasgow AM; Brallier J; Pietrzak RH; Murrough JW; Charney DS
    Am J Psychiatry; 2021 Feb; 178(2):193-202. PubMed ID: 33397139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine versus placebo in posttraumatic stress disorder.
    Martenyi F; Brown EB; Zhang H; Prakash A; Koke SC
    J Clin Psychiatry; 2002 Mar; 63(3):199-206. PubMed ID: 11926718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.